RPTXRepare Therapeutics Inc
RPTX
Repare Therapeutics Inc1,033
Mkt Cap
$92.25MVolume
834,859.0052W High
$2.3052W Low
$0.89PE Ratio
-1.30RPTX Fundamentals
Price
$2.20Prev Close
$2.14Open
$2.1450D MA
$1.95Beta
1.03Avg. Volume
1.21MEPS (Annual)
-$2.00P/B
0.82Rev/Employee
$414,550.39Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages THS, RPTX, AXTA Shareholders to Contact the Firm to Discuss Their...
PR Newswire·17d ago
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR
HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the Merger - RPTX, AXTA, WTG and SEMR HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm...
PR Newswire·18d ago
Repare Therapeutics Inc. (NASDAQ:RPTX) Receives Consensus Recommendation of "Hold" from Analysts
Repare Therapeutics Inc. (NASDAQ:RPTX - Get Free Report) has been given an average recommendation of "Hold" by the seven brokerages that are covering the company, Marketbeat Ratings reports. One...
MarketBeat·22d ago
Repare Therapeutics Enters into Support and Voting Agreements with Significant Shareholders for Proposed Transaction with XenoTherapeutics, Inc.
Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a clinical-stage precision oncology company, today announced that following the announcement on November 14, 2025 of the entering into...
Business Wire·25d ago
Stock Traders Purchase High Volume of Call Options on Repare Therapeutics (NASDAQ:RPTX)
Repare Therapeutics Inc. (NASDAQ:RPTX - Get Free Report) saw some unusual options trading activity on Monday. Stock investors bought 13,699 call options on the stock. This represents an increase of...
MarketBeat·27d ago
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to Discuss Their Rights Halper Sadeh LLC Encourages RPTX, SEE, CDTX, MRSN Shareholders to Contact the Firm to...
PR Newswire·28d ago
Repare Therapeutics Agrees To Acquisition As Board Cites Best Path For Stakeholder Value
Repare Therapeutics agrees to be acquired by XenoTherapeutics, offering shareholders cash, CVRs, and future milestone potential as the deal targets an early 2026 closing.read more...
Benzinga·28d ago
RPTX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Repare Therapeutics Inc. is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Repare Therapeutics Inc. (NASDAQ: RPTX) to XenoTherapeutics, Inc. is fair to Repare shareholders. Upon closing of...
Business Wire·1mo ago
Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders
Shareholder Alert: The Ademi Firm investigates whether Repare Therapeutics Inc. is obtaining a Fair Price for its Public Shareholders Shareholder Alert: The Ademi Firm investigates whether Repare...
PR Newswire·1mo ago
Repare Therapeutics Inc. (RPTX) Reports Break-Even Earnings for Q3
Repare Therapeutics (RPTX) delivered earnings and revenue surprises of +100.00% and +132.40%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
<
1
2
...
>